Clinicopathological cohort study of kidney biopsy findings resulting in dialysis during long-term follow-up exceeding 30 years
- PMID: 40434507
- DOI: 10.1007/s10157-025-02706-8
Clinicopathological cohort study of kidney biopsy findings resulting in dialysis during long-term follow-up exceeding 30 years
Abstract
Background: Numerous kidney diseases progress to end-stage kidney disease (ESKD); however, a limited number of cohort studies have evaluated the underlying kidney diseases through kidney biopsy (KB).
Methods: We retrospectively evaluated all patients who initiated dialysis at Toranomon Hospital, Japan, from 1985 to 2019, and whose underlying kidney disease had been diagnosed by KB. The data on histopathological diagnosis and various clinical characteristics were collected and analyzed for 357 patients.
Results: The most prevalent underlying diseases, which constituted the primary endpoint of this study, were diabetic nephropathy (DN; n = 100, 28.0%), IgA nephropathy (IgAN; n = 99, 27.7%), and focal segmental glomerulosclerosis (n = 34, 9.5%). Benign nephrosclerosis (BNS; n = 1, 0.3%), that is, arteriosclerosis/arteriolosclerosis without distinct glomerulopathy, was rare. As the secondary endpoint, Cox regression analysis revealed that lower eGFR (p < 0.0001), higher proteinuria (p < 0.0001), older age (p = 0.005) and presence of DN (p = 0.008) were significant independent risk factors for early dialysis initiation. In the subgroup analysis, when comparing DN and IgAN, significantly earlier dialysis initiation was observed in DN than in IgAN by log-rank analysis (p < 0.0001), as well as after adjustment for baseline clinical characteristics using propensity score matching (n = 45 each) (p = 0.023).
Conclusions: We identified a list of kidney diseases that were at risk for ESKD at the time of KB through a long-term follow-up. DN and IgAN are the two primary causes of ESKD, whereas BNS is an infrequent direct cause of ESKD in patients requiring kidney biopsy.
Keywords: Benign nephrosclerosis; Diabetic nephropathy; End stage kidney disease; IgA nephropathy; Kidney biopsy.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no competing financial interests related to this work.
Similar articles
-
The Significance of Crescents on the Clinical Features and Outcomes of Primary Immunoglobin A Nephropathy.Front Med (Lausanne). 2022 Jun 29;9:864667. doi: 10.3389/fmed.2022.864667. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35847826 Free PMC article.
-
Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study.Nephrology (Carlton). 2016 May;21(5):387-96. doi: 10.1111/nep.12629. Nephrology (Carlton). 2016. PMID: 26393772
-
Remnant cholesterol and the risk of diabetic nephropathy progression to end-stage kidney disease in patients with type 2 diabetes mellitus: a longitudinal cohort study.Endocrine. 2024 Dec;86(3):994-1002. doi: 10.1007/s12020-024-03948-4. Epub 2024 Jul 12. Endocrine. 2024. PMID: 39126619 Free PMC article.
-
Clinical decision support system for end-stage kidney disease risk estimation in IgA nephropathy patients.Nephrol Dial Transplant. 2016 Jan;31(1):80-6. doi: 10.1093/ndt/gfv232. Epub 2015 Jun 4. Nephrol Dial Transplant. 2016. PMID: 26047632
-
Immunoglobulin A nephropathy in association with inflammatory bowel diseases: results from a national study and systematic literature review.Nephrol Dial Transplant. 2022 Feb 25;37(3):531-539. doi: 10.1093/ndt/gfaa378. Nephrol Dial Transplant. 2022. PMID: 33416845
References
-
- Nitta K, Goto S, Masakane I, Hanafusa N, Taniguchi M, Hasegawa T, et al. Annual dialysis data report for 2018, JSDT Renal Data Registry: survey methods, facility data, incidence, prevalence, and mortality. Renal Replacement Therapy. 2020;6(1):41. https://doi.org/10.1186/s41100-020-00286-9 . - DOI
-
- Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Johansen K, et al. ’United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis. 2012;59(1):e1-420. https://doi.org/10.1053/j.ajkd.2011.11.015 . - DOI
-
- Navaratnarajah A, Sambasivan K, Cook TH, Pusey C, Roufosse C, Willicombe M. Predicting long-term renal and patient survival by clinicopathological features in elderly patients undergoing a renal biopsy in a UK cohort. Clin Kidney J. 2019;12(4):512–20. https://doi.org/10.1093/ckj/sfz006 . - DOI - PubMed - PMC
-
- Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982–92. https://doi.org/10.1053/j.ajkd.2008.12.034 . - DOI - PubMed
-
- Hiramatsu R, Hoshino J, Suwabe T, Sumida K, Hasegawa E, Yamanouchi M, et al. Membranoproliferative glomerulonephritis and circulating cryoglobulins. Clin Exp Nephrol. 2014;18(1):88–94. https://doi.org/10.1007/s10157-013-0810-z . - DOI - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous